Business news with perspective

AGT Food and Ingredients' Q2 results signal a successful shift to higher-margin foods, with its packaged foods segment surging despite global headwinds.

With a second secret, multi-billion-dollar deal, Pure Storage is outmaneuvering giants to power the AI era. It's a quiet war for the data center's soul.

National Health Investors' Q2 results reveal a bold strategy: selling a $560M legacy portfolio to fuel an aggressive expansion into private-pay senior housing.

MySize Inc. is consolidating its shares to stay on Nasdaq. We go beyond the press release to analyze if this financial maneuver is a path to stability or a warning sign.

The NAIC's summer summit in Columbus places the city's robust insurance ecosystem at the center of national debates on AI governance, climate risk, and state regulation.

Sirion's top-tier IRAP security clearance in Australia is more than compliance; it's a strategic key to a lucrative market and a new benchmark for trust in AI.

Tyson Foods' $1B bond offering isn't just about money. It's a calculated move to reshape its debt, signal market confidence, and fuel its global mission.

Gencor Industries posted a stellar quarter with an 85% jump in operating income, fueled by a record backlog. But is this just a cyclical peak?

Security National Financial boosts profits despite falling revenue, revealing a masterclass in operational efficiency and a long-term strategy that defies convention.

Draganfly posts 26% revenue growth and secures major defense contracts, but a widening comprehensive loss reveals the high cost of its aggressive expansion strategy.

With promising early data and a robust balance sheet, Palisade Bio is advancing its targeted IBD therapy, PALI-2108, into crucial Phase 2 trials.

FutureFuel's stunning $25.6M profit swing reveals a blueprint for resilience, powered by regulatory tailwinds in biofuels and reshoring in chemicals.

Amplify Energy touts a major profit swing and a new stock buyback, but a look under the hood reveals a complex picture of derivative gains and real-world challenges.

Angie O'Leary's promotion at Commercial Vehicle Group is more than a new title. It's a strategic bet on continuity to navigate a turbulent EV transition.

Insight Molecular Diagnostics has key regulatory and reimbursement wins for its game-changing transplant test, but a high cash burn creates a high-stakes race to commercialization.

Tactile Medical's impressive Q2 profit growth is tempered by a product launch stumble, testing its execution as it places big bets on new markets and tech.

Shimmick Corp. posts improving financials and a record backlog, but a closer look reveals the high cost of its strategic pivot from troubled legacy projects.

Alico's Q3 results reveal a successful pivot from citrus giant to land developer, with profits soaring and major projects advancing. How is this changing Florida?

Metagenomi Therapeutics is on track for a pivotal 2027 clinical trial, but its advanced gene editing tech faces a market wary of high-cost cures.

Strong Attruby sales and new data showing superiority fuel BridgeBio’s momentum as it prepares for three FDA decisions, backed by a new $1B financing.